Two Sigma Securities, LLC Sarepta Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $286,195 - $409,783	-4,532 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $350,232 - $450,571	4,532 New	4,532 $408,000
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $120,296 - $281,301	-1,665 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $209,057 - $297,602	1,665 New	1,665 $284,000
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $612,412 - $978,611	-7,434 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $568,924 - $1.01 Million	7,434 New	7,434 $959,000
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $211,099 - $300,174	-1,979 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $192,596 - $294,396	1,979 New	1,979 $216,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.